{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:29:03Z","timestamp":1780662543412,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,3]]},"DOI":"10.7759\/cureus.19231","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T15:05:52Z","timestamp":1635951952000},"source":"Crossref","is-referenced-by-count":6,"title":["Generic Anticancer Drugs of the Jan Aushadhi Scheme in India and Their Branded Counterparts: The First Cost Comparison Study"],"prefix":"10.7759","author":[{"given":"Thomas","family":"George","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjeshwar S","family":"Baliga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70115-9","article-title":"The growing burden of cancer in India: epidemiology and social context","volume":"15","author":"Mallath MK","year":"2014","unstructured":"Mallath MK, Taylor DG, Badwe RA, et al.. The growing burden of cancer in India: epidemiology and social context. Lancet Oncol. 2014, 15:e205-12. 10.1016\/S1470-2045(14)70115-9","journal-title":"Lancet Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193320","article-title":"Economic burden of cancer in India: evidence from cross-sectional nationally representative household survey, 2014","volume":"13","author":"Rajpal S","year":"2018","unstructured":"Rajpal S, Kumar A, Joe W. Economic burden of cancer in India: evidence from cross-sectional nationally representative household survey, 2014. PLoS One. 2018, 13:e0193320. 10.1371\/journal.pone.0193320","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30447-9","article-title":"The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016","volume":"19","year":"2018","unstructured":"The burden of cancers and their variations across the states of India. the Global Burden of Disease Study 1990-2016. Lancet Oncol. 2018, 19:1289-306. 10.1016\/S1470-2045(18)30447-9","journal-title":"Lancet Oncol"},{"key":"ref4","article-title":"DeVita, Hellman, And Rosenberg's Cancer: Principles & Practice Of Oncology, 8th ed","year":"2008","unstructured":"DeVita, Hellman, And Rosenberg's Cancer. Principles & Practice Of Oncology, 8th ed. DeVita Jr VT, Rosenberg SA, Lawrence TS (ed): Lippincott Williams & Wilkins, Philadelphia, PA; 2008."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-020-4930-3","article-title":"The impact of tumor board on cancer care: evidence from an umbrella review","volume":"20","author":"Specchia ML","year":"2020","unstructured":"Specchia ML, Frisicale EM, Carini E, et al.. The impact of tumor board on cancer care: evidence from an umbrella review. BMC Health Serv Res. 2020, 20:73. 10.1186\/s12913-020-4930-3","journal-title":"BMC Health Serv Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.3635","article-title":"Cancer and radiation therapy: current advances and future directions","volume":"9","author":"Baskar R","year":"2012","unstructured":"Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012, 9:193-9. 10.7150\/ijms.3635","journal-title":"Int J Med Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.119314","article-title":"Cost analysis of in-patient cancer chemotherapy at a tertiary care hospital","volume":"9","author":"Wani MA","year":"2013","unstructured":"Wani MA, Tabish SA, Jan FA, Khan NA, Wafai ZA, Pandita KK. Cost analysis of in-patient cancer chemotherapy at a tertiary care hospital. J Cancer Res Ther. 2013, 9:397-401. 10.4103\/0973-1482.119314","journal-title":"J Cancer Res Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17742","article-title":"A global comparison of the cost of patented cancer drugs in relation to global differences in wealth","volume":"8","author":"Goldstein DA","year":"2017","unstructured":"Goldstein DA, Clark J, Tu Y, et al.. A global comparison of the cost of patented cancer drugs in relation to global differences in wealth. Oncotarget. 2017, 8:71548-55. 10.18632\/oncotarget.17742","journal-title":"Oncotarget"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/0019-509X.146723","article-title":"Toward better quality of anticancer generics in India","volume":"51","author":"Gota VS","year":"2014","unstructured":"Gota VS, Patial P. Toward better quality of anticancer generics in India. Indian J Cancer. 2014, 51:366-8. 10.4103\/0019-509X.146723","journal-title":"Indian J Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.15171\/ijhpm.2017.02","article-title":"A cost analysis of the Jan Aushadhi scheme in India","volume":"6","author":"Mukherjee K","year":"2017","unstructured":"Mukherjee K. A cost analysis of the Jan Aushadhi scheme in India. Int J Health Policy Manag. 2017, 6:253-6. 10.15171\/ijhpm.2017.02","journal-title":"Int J Health Policy Manag"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/jpp.JPP_38_17","article-title":"Why the Jan Aushadhi scheme has lost its steam in India?","volume":"8","author":"Thawani V","year":"2017","unstructured":"Thawani V, Mani A, Upmanyu N. Why the Jan Aushadhi scheme has lost its steam in India?. J Pharmacol Pharmacother. 2017, 8:134-6. 10.4103\/jpp.JPP_38_17","journal-title":"J Pharmacol Pharmacother"},{"key":"ref12","article-title":"Jan Aushadhi stores in India and quality of medicines therein","volume":"3","author":"Singhal GL","year":"2011","unstructured":"Singhal GL, Anita K, Arun N. Jan Aushadhi stores in India and quality of medicines therein. Int J Pharm Sci. 2011, 3:204-7.","journal-title":"Int J Pharm Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2019.1637735","article-title":"Cost analysis of various branded versus generic chemotherapeutic agents used for the treatment of early breast cancer- a deep insight from India","volume":"20","author":"Kashyap A","year":"2020","unstructured":"Kashyap A, Balaji MN, Chhabra M, Rashid M, Muragundi PM. Cost analysis of various branded versus generic chemotherapeutic agents used for the treatment of early breast cancer- a deep insight from India. Expert Rev Pharmacoecon Outcomes Res. 2020, 20:355-61. 10.1080\/14737167.2019.1637735","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2016\/22384.8918","article-title":"Variation of cost among anti-cancer drugs available in Indian market","volume":"10","author":"Kolasani BP","year":"2016","unstructured":"Kolasani BP, Malathi DC, Ponnaluri RR. Variation of cost among anti-cancer drugs available in Indian market. J Clin Diagn Res. 2016, 10:FC17-20. 10.7860\/JCDR\/2016\/22384.8918","journal-title":"J Clin Diagn Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2018.02.019","article-title":"A cost analysis of the psychotropic medicines sold in the jan aushadhi generic drug stores in India","volume":"33","author":"Uvais NA","year":"2018","unstructured":"Uvais NA. A cost analysis of the psychotropic medicines sold in the jan aushadhi generic drug stores in India. Asian J Psychiatr. 2018, 33:40-1. 10.1016\/j.ajp.2018.02.019","journal-title":"Asian J Psychiatr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7964","article-title":"A cost variation analysis of drugs available in the Indian market for the management of thromboembolic disorders","volume":"12","author":"Ray A","year":"2020","unstructured":"Ray A, Najmi A, Khandelwal G, Sadasivam B. A cost variation analysis of drugs available in the Indian market for the management of thromboembolic disorders. Cureus. 2020, 12:e7964. 10.7759\/cureus.7964","journal-title":"Cureus"},{"key":"ref17","unstructured":"Pharmaceuticals & Medical Devices Bureau of India (PMBI). PMBJP products. (2021). Accessed: August 28, 2021: http:\/\/janaushadhi.gov.in\/ProductList.aspx."},{"key":"ref18","unstructured":"CIMS. Search drug information, images & medical news. (2021). Accessed: August 28, 2021: https:\/\/www.mims.com\/india."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2018.03.28","article-title":"Financial toxicity and implications for cancer care in the era of molecular and immune therapies","volume":"6","author":"Tran G","year":"2018","unstructured":"Tran G, Zafar SY. Financial toxicity and implications for cancer care in the era of molecular and immune therapies. Ann Transl Med. 2018, 6:166. 10.21037\/atm.2018.03.28","journal-title":"Ann Transl Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2016.07.006","article-title":"Platinum based radiochemotherapies: Free radical mechanisms and radiotherapy sensitizers","volume":"99","author":"Fong CW","year":"2016","unstructured":"Fong CW. Platinum based radiochemotherapies: Free radical mechanisms and radiotherapy sensitizers. Free Radic Biol Med. 2016, 99:99-109. 10.1016\/j.freeradbiomed.2016.07.006","journal-title":"Free Radic Biol Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10993","article-title":"Systematic review of treatment intensification using novel agents for chemoradiotherapy in rectal cancer","volume":"105","author":"Clifford R","year":"2018","unstructured":"Clifford R, Govindarajah N, Parsons JL, Gollins S, West NP, Vimalachandran D. Systematic review of treatment intensification using novel agents for chemoradiotherapy in rectal cancer. Br J Surg. 2018, 105:1553-72. 10.1002\/bjs.10993","journal-title":"Br J Surg"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/s0149-2918(03)80327-2","article-title":"Zoledronic acid: a new parenteral bisphosphonate","volume":"25","author":"Li EC","year":"2003","unstructured":"Li EC, Davis LE. Zoledronic acid: a new parenteral bisphosphonate. Clin Ther. 2003, 25:2669-708. 10.1016\/s0149-2918(03)80327-2","journal-title":"Clin Ther"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.77344","article-title":"A comparative evaluation of price and quality of some branded versus branded-generic medicines of the same manufacturer in India","volume":"43","author":"Singal GL","year":"2011","unstructured":"Singal GL, Nanda A, Kotwani A. A comparative evaluation of price and quality of some branded versus branded-generic medicines of the same manufacturer in India. Indian J Pharmacol. 2011, 43:131-6. 10.4103\/0253-7613.77344","journal-title":"Indian J Pharmacol"},{"key":"ref24","doi-asserted-by":"crossref","DOI":"10.4103\/jpgm.JPGM_420_18","article-title":"Generic drugs - the Indian scenario","volume":"65","author":"Joshi SS","year":"2019","unstructured":"Joshi SS, Shetty YC, Karande S. Generic drugs - the Indian scenario. J Postgrad Med. 2019, 65:67-9.","journal-title":"J Postgrad Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.04.004","article-title":"Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved?","volume":"15","author":"Cameron A","year":"2012","unstructured":"Cameron A, Mantel-Teeuwisse AK, Leufkens HG, Laing RO. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved?. Value Health. 2012, 15:664-73. 10.1016\/j.jval.2012.04.004","journal-title":"Value Health"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00449-0","article-title":"Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study","volume":"17","author":"Vogler S","year":"2016","unstructured":"Vogler S, Vitry A, Babar ZU. Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study. Lancet Oncol. 2016, 17:39-47. 10.1016\/S1470-2045(15)00449-0","journal-title":"Lancet Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2012.1263","article-title":"Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis","volume":"32","author":"Ramsey S","year":"2013","unstructured":"Ramsey S, Blough D, Kirchhoff A, et al.. Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood). 2013, 32:1143-52. 10.1377\/hlthaff.2012.1263","journal-title":"Health Aff (Millwood)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-020-01424-3","article-title":"Economic perspective of cancer treatment in India","volume":"37","author":"Natarajan A","year":"2020","unstructured":"Natarajan A, Mehra N, Rajkumar T. Economic perspective of cancer treatment in India. Med Oncol. 2020, 37:101. 10.1007\/s12032-020-01424-3","journal-title":"Med Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/jjns.12020","article-title":"Cost information of chemotherapy for cervical and endometrial cancer in Japan","volume":"11","author":"Kamijo Y","year":"2014","unstructured":"Kamijo Y, Ichikawa M. Cost information of chemotherapy for cervical and endometrial cancer in Japan. Jpn J Nurs Sci. 2014, 11:190-9. 10.1111\/jjns.12020","journal-title":"Jpn J Nurs Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/69040-generic-anticancer-drugs-of-the-jan-aushadhi-scheme-in-india-and-their-branded-counterparts-the-first-cost-comparison-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T11:19:39Z","timestamp":1726053579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/69040-generic-anticancer-drugs-of-the-jan-aushadhi-scheme-in-india-and-their-branded-counterparts-the-first-cost-comparison-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,3]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.19231","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,3]]}}}